RhumbLine Advisers
USNA icon

RhumbLine Advisers’s Usana Health Sciences USNA Stock Holding History

RhumbLine Advisers’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Sell
14,510
-984
-6% -$18.5K ﹤0.01% 3055
2026
Q1 		$271K Sell
15,494
-273
-2% -$5.42K ﹤0.01% 2961
2025
Q4 		$309K Sell
15,767
-18,184
-54% -$377K ﹤0.01% 2949
2025
Q3 		$935K Sell
33,951
-85
-0.2% -$2.62K ﹤0.01% 2287
2025
Q2 		$1.04M Sell
34,036
-2,269
-6% -$64.4K ﹤0.01% 2228
2025
Q1 		$979K Sell
36,305
-13,085
-26% -$414K ﹤0.01% 2182
2024
Q4 		$1.77M Buy
49,390
+14,068
+40% +$526K ﹤0.01% 1947
2024
Q3 		$1.34M Sell
35,322
-1,164
-3% -$47.8K ﹤0.01% 2110
2024
Q2 		$1.65M Buy
36,486
+2,425
+7% +$112K ﹤0.01% 1987
2024
Q1 		$1.65M Sell
34,061
-444
-1% -$21.7K ﹤0.01% 1993
2023
Q4 		$1.85M Sell
34,505
-437
-1% -$22.1K ﹤0.01% 1955
2023
Q3 		$2.05M Buy
34,942
+496
+1% +$31K ﹤0.01% 1845
2023
Q2 		$2.17M Sell
34,446
-473
-1% -$30.1K ﹤0.01% 1855
2023
Q1 		$2.2M Buy
34,919
+1,837
+6% +$110K ﹤0.01% 1760
2022
Q4 		$1.76M Buy
33,082
+1,680
+5% +$91K ﹤0.01% 1846
2022
Q3 		$1.76M Sell
31,402
-142
-0.5% -$9.39K ﹤0.01% 1830
2022
Q2 		$2.28M Buy
31,544
+362
+1% +$27K ﹤0.01% 1697
2022
Q1 		$2.48M Buy
31,182
+2,297
+8% +$207K ﹤0.01% 1698
2021
Q4 		$2.92M Sell
28,885
-850
-3% -$84.8K ﹤0.01% 1687
2021
Q3 		$2.74M Sell
29,735
-4,081
-12% -$393K ﹤0.01% 1714
2021
Q2 		$3.46M Sell
33,816
-716
-2% -$71.9K ﹤0.01% 1640
2021
Q1 		$3.37M Buy
34,532
+650
+2% +$59.2K ﹤0.01% 1630
2020
Q4 		$2.61M Sell
33,882
-199
-0.6% -$15.4K ﹤0.01% 1711
2020
Q3 		$2.51M Sell
34,081
-3,642
-10% -$292K ﹤0.01% 1551
2020
Q2 		$2.77M Sell
37,723
-4,200
-10% -$329K ﹤0.01% 1545
2020
Q1 		$2.42M Buy
41,923
+1,143
+3% +$79.5K 0.01% 1446
2019
Q4 		$3.2M Buy
40,780
+1,264
+3% +$93.1K 0.01% 1519
2019
Q3 		$2.7M Buy
39,516
+8,710
+28% +$585K ﹤0.01% 1565
2019
Q2 		$2.45M Buy
30,806
+13,750
+81% +$1.09M ﹤0.01% 1610
2019
Q1 		$1.43M Sell
17,056
-60
-0.4% -$6.26K ﹤0.01% 1880
2018
Q4 		$2.02M Buy
17,116
+5,532
+48% +$640K ﹤0.01% 1636
2018
Q3 		$1.4M Sell
11,584
-756
-6% -$93.8K ﹤0.01% 1849
2018
Q2 		$1.42M Buy
12,340
+1,685
+16% +$184K ﹤0.01% 1858
2018
Q1 		$915K Sell
10,655
-427
-4% -$33.1K ﹤0.01% 1980
2017
Q4 		$821K Sell
11,082
-1,973
-15% -$132K ﹤0.01% 2035
2017
Q3 		$753K Buy
13,055
+145
+1% +$8.57K ﹤0.01% 2121
2017
Q2 		$828K Buy
12,910
+664
+5% +$40.9K ﹤0.01% 2042
2017
Q1 		$705K Buy
12,246
+349
+3% +$20.8K ﹤0.01% 2095
2016
Q4 		$728K Buy
11,897
+461
+4% +$30K ﹤0.01% 2021
2016
Q3 		$791K Buy
11,436
+304
+3% +$20.1K ﹤0.01% 1952
2016
Q2 		$620K Sell
11,132
-122
-1% -$7.36K ﹤0.01% 2066
2016
Q1 		$683K Buy
11,254
+38
+0.3% +$2.24K ﹤0.01% 2022
2015
Q4 		$716K Sell
11,216
-596
-5% -$38.7K ﹤0.01% 2026
2015
Q3 		$792K Buy
11,812
+368
+3% +$26K ﹤0.01% 1921
2015
Q2 		$782K Sell
11,444
-918
-7% -$58.3K ﹤0.01% 2037
2015
Q1 		$687K Buy
12,362
+1,392
+13% +$71.3K ﹤0.01% 2097
2014
Q4 		$563K Sell
10,970
-1,308
-11% -$64.2K ﹤0.01% 2205
2014
Q3 		$452K Buy
12,278
+360
+3% +$13K ﹤0.01% 2270
2014
Q2 		$466K Sell
11,918
-1,240
-9% -$46K ﹤0.01% 2321
2014
Q1 		$496K Sell
13,158
-580
-4% -$20.3K ﹤0.01% 2234
2013
Q4 		$519K Sell
13,738
-80
-0.6% -$3.06K ﹤0.01% 2234
2013
Q3 		$600K Sell
13,818
-176
-1% -$7.06K ﹤0.01% 2100
2013
Q2 		$506K Buy
+13,994
New +$425K ﹤0.01% 2246

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RhumbLine Advisers's USNA Position: Q2 2026 in Review

RhumbLine Advisers reduced its Usana Health Sciences (USNA) stake by 6.4% in Q2 2026, selling an estimated $18.5K and leaving 14,510 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

RhumbLine Advisers first reported a position in USNA in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.46M in Q2 2021. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • RhumbLine Advisers held 14,510 shares of Usana Health Sciences worth $310K as of Q2 2026.
  • RhumbLine Advisers sold 984 Usana Health Sciences shares in Q2 2026, an estimated $18.5K.
  • Usana Health Sciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3055 holding.
  • RhumbLine Advisers first reported a position in Usana Health Sciences in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Usana Health Sciences position peaked at $3.46M in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.